人巨细胞病毒DNA疫苗免疫效果的初步研究

人巨细胞病毒(HCMV)是广泛感染人类的重要病原体之一,在人群中有较高的感染率,胎儿、婴儿、器官移植及免疫缺陷者等更易感染.现有的抗HCMV药物治疗及被动免疫由于毒性大、价格昂贵及短效性等原因,应用大受限制,为此研制安全、有效的疫苗即成为防治HCMV疾病的重要手段.HCMV具有潜在的致癌作用,不宜发展活疫苗或含完整病毒DNA的死疫苗;亚单位疫苗虽然比较安全,但所用抗原不能在宿主细胞内表达,只能诱导体液免疫,这对于胞内感染的HCMV预防效果较差;通过新佐剂的应用,虽可引发细胞免疫,但免疫原性较差,且成本较高.因此,目前倾向于研制具有免疫原性的HCMV DNA疫苗.

Immune Response Induced by Human Cytomegalovirus DNA Vaccine

Human cytomegalovirus is an important pathogen which widely infects human. In this study, an eukaryotic expression vector containing human cytomegalovirus gB680 and pp65m genes was injected into BALB/c mice to explore the immune response. Firstly, the recombinant plasmid pVAX1/gB680+pp65m and plasmid pVAX1 were transfected into COS-7 cells respectively and the transiently expressed product was detected by RT-PCR and Western blot. The maxiprepared plasmid pVAX1/gB680 + pp65m and pVAX1 by alkaline lysis with SDS and purified by Sepharose 4FF column chromatography were then used to immunize BALB/c mice and the humoral and cellular immune responses were determined. Recombinant plasmid pVAX1/gB680+pp65m could be expressed in COS-7 cells, and could induce antibodies and cellular immune responses in BALB/c mice.